Cyclerion Therapeutics annual operating margin
2019
2020
2021
2022
2024
2025
Cyclerion Therapeutics's operating margin was −239.78% for fiscal 2025.
View full Cyclerion Therapeutics company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −239.78% | −58.38 pp |
| 2024 | 2024-12-31 | −181.40% | +6061.02 pp |
| 2022 | 2022-12-31 | −6,242.42% | −4842.25 pp |
| 2021 | 2021-12-31 | −1,400.18% | +2139.24 pp |
| 2020 | 2020-12-31 | −3,539.42% | −765.13 pp |
| 2019 | 2019-12-31 | −2,774.28% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q4 2025 | 2025-12-31 | −81.76% | −109.55 pp |
| Q3 2025 | 2025-09-30 | −114.97% | +466.47 pp |
| Q2 2025 | 2025-06-30 | −1,797.85% | +2592.02 pp |
| Q1 2025 | 2025-03-31 | −1,798.77% | +27.39 pp |
| Q4 2024 | 2024-12-31 | 27.80% | +2723.10 pp |
| Q3 2024 | 2024-09-30 | −581.44% | +2661.37 pp |
| Q2 2022 | 2022-06-30 | −4,389.87% | −3850.67 pp |
| Q1 2022 | 2022-03-31 | −1,826.16% | +19778.68 pp |
| Q4 2021 | 2021-12-31 | −2,695.30% | +11758.83 pp |
| Q3 2021 | 2021-09-30 | −3,242.82% | +2202.18 pp |
| Q2 2021 | 2021-06-30 | −539.20% | +2087.24 pp |
| Q1 2021 | 2021-03-31 | −21,604.84% | −19574.37 pp |
| Q4 2020 | 2020-12-31 | −14,454.14% | −12450.13 pp |
| Q3 2020 | 2020-09-30 | −5,445.00% | −3414.66 pp |
| Q2 2020 | 2020-06-30 | −2,626.44% | — |
| Q1 2020 | 2020-03-31 | −2,030.47% | — |
| Q3 2019 | 2019-09-30 | −2,004.01% | — |
| Q2 2019 | 2019-06-30 | −2,030.34% | — |
Over the last five reported fiscal years, Cyclerion Therapeutics's operating margin increased from −2,774.28% to −239.78%, a change of +2534.51 percentage points. The latest reported quarter, Q4 2025, shows −81.76%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cyclerion Therapeutics filings at SEC.gov ↗